Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease. [electronic resource]
Producer: 20041208Description: 4541-50 p. digitalISSN:- 0732-183X
- Adolescent
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Child
- Child, Preschool
- Combined Modality Therapy
- Cyclophosphamide -- administration & dosage
- Disease Progression
- Disease-Free Survival
- Doxorubicin -- administration & dosage
- Female
- Hodgkin Disease -- drug therapy
- Humans
- Male
- Methotrexate -- administration & dosage
- Prednisone -- administration & dosage
- Procarbazine -- administration & dosage
- Prognosis
- Risk Assessment
- Treatment Outcome
- Vinblastine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.